Jan. 13, 2020News & Opinions
A new study published in the Journal of the American Medical Association (JAMA), which found “no statistically significant association” between genital talc use and ovarian cancer, could aid Johnson & Johnson in dealing ...
Jan. 06, 2020News & Opinions
US healthcare giant Johnson & Johnson has been on a roller coaster ride for around two years, and its fortunes – along with its share price – continued moving up and down as 2019 gave way to 2020.
Nov. 21, 2019News & Opinions
Oklahoma judge Thad Balkman has reduced the fine levied on Johnson & Johnson in a landmark opioid case concluded in August by $107 million, from $57 2million to $465 million. The reduction takes account of the court’s ...
Oct. 22, 2019News & Opinions
After negotiating through the night, Israeli generics giant Teva – which is a leading supplier of the US market – and the three biggest US drug distributors on Oct. 21 reached a $260 million settlement with two Ohio counties ...
Oct. 21, 2019News & Opinions
Johnson & Johnson (J&J) has voluntarily recalled 33,000 bottles of its iconic baby powder in the US, after the Food and Drug Administration (FDA) found traces of asbestos in one batch.
Oct. 17, 2019News & Opinions
Long anticipated bundled proceedings against opioid manufacturers and US opioid distributors began on Oct. 16 in a US court in Cleveland, Ohio, where cases against Israeli generics giant Teva and five distributors were to be heard.
Oct. 10, 2019News & Opinions
A jury in Philadelphia, Pennsylvania, has ordered US healthcare giant Johnson & Johnson (J&J) to pay $8 billion in punitive damages to a man who claims the company’s anti-psychotic drug Risperdal caused him to grow breasts.
Sep. 03, 2019News & Opinions
After Johnson & Johnson last week was ordered to pay $572 million to the state of Oklahoma, analysts and other observers said the verdict could prompt other opioid makers to think more seriously about settling.
Jul. 19, 2019News & Opinions
Still facing thousands of lawsuits claiming that its talc products caused the plaintiffs’ cancer, US healthcare giant Johnson & Johnson (J&J) has won some smaller cases and lost bigger ones – which it is appealing.
Feb. 06, 2019News & Opinions
Janssen, the pharmaceuticals arm of Johnson & Johnson, is once again collaborating with US clinical-stage gene therapy company MeiraGTx to develop and commercialize treatments for inherited retinal diseases (IRDs).
The latest information directly via newsletter.